Connect with us

Cannabis News

Top Veterans Group Warns Congress That Hemp Ban Could ‘Slam The Door Shut’ On Medical Research

Published

1 month ago

on

A leading veterans’ organization has warned congressional leaders that a newly approved blanket ban on consumable hemp products could inadvertently “close the door” on critical research.

In a letter to House and Senate leaders on Wednesday, American Veterans of Foreign Wars (VFW) executives stressed the importance of “supporting robust scientific research into hemp-derived cannabinoids,” which they said could be at risk. President Donald Trump has signed provisions of a spending bill into law.

Hemp-based cannabinoid products “can offer a real alternative to heavy prescription drugs, so many of our veterans prescribe them for PTSD, anxiety, pain and sleep problems,” wrote the VFW’s Carol Whitmore and Dan West.

“Every day, doctors dispense powerful sedatives and psychoactive drugs to help veterans cope. They work for some, but they’re too hooked, numb, or dealing with brutal side effects,” they wrote. “We’ve all seen good men and women get caught in a cycle of pills that dull the pain but don’t fix the problem.”

“It’s time to explore safer options. Early research on certain hemp compounds suggests they can manage symptoms and reduce physical pain without the risk of addiction,” the letter says, citing recent research showing that hemp-derived cannabinoids improve PTSD symptoms and may be an effective alternative treatment for pain and anxiety.

“This is not evidence of a miracle cure, just clear signs that we should continue to study. But broad movements to ‘close the hemp loophole’ could close the door. A blanket ban on hemp cannabinoids would make it nearly impossible for researchers and (US Department of Veterans Affairs) hospitals to examine the rules by which even small businesses that have legally acquired these compounds are acting legally. Seriously, it would drive veterans seeking relief into black market junk, making things more dangerous. making it not safer.”

The VFW said it is not promoting “wild, unregulated products or recreational use,” but instead “is calling for smart policy: protect the public, but don’t kill research.”

“Let science do its job, regulate what’s proven safe, and give veterans every legitimate tool available to reclaim their lives,” the letter says. “Our veterans have earned the best care we can give them. We urge Congress to take a balanced approach that protects consumers, promotes research, and gives veterans hope for safer alternatives.”

In the last month, The VFW announced that it has entered into a first-of-its-kind partnership with hemp THC beverage company Torch Drinkswith a licensed branding agreement to support various veterans services and promote cannabis beverages as a potential alternative to alcohol. In addition to the brand licensing agreement, the cannabis beverages will be available at VFW posts across the country in jurisdictions where they are locally legal.

Debate over the current appropriations bill’s hemp ban has been fueled by some who believe recriminalizing cannabis products will alleviate public health concerns, particularly regarding youth access to unregulated markets, and others who insist Congress should address the challenges by enacting regulations, including age requirements and testing requirements.

Many hemp participants argue that a ban would effectively wipe out the industry, even if enforced Non-toxic CBD products that people use for medical reasons— There is a hidden hope that they can reach an agreement with the legislators before the ban is implemented next year.

Lawmakers like Sen. Chris Van Hollen (D-MD) also say the window could allow them to advance legislation to create an alternative regulatory model for consumer hemp products.

There were Attempts by GOP lawmakers in both chambers to kill the hemp ban provision. But amendments proposed by Senators Rand Paul (R-KY) and Thomas Massie (R-KY) were not included in the final package.

On the Senate side, Paul was joined by 22 Democrats, and especially Sen. Ted Cruz (R-TX) anti-marijuana: voting against the motion to introduce the amendment to avoid the ban, but was eventually overturned by the majority.

Massie tried to revive momentum in the House with an amendment mirroring Paul’s, but its chances of passage were dubious at best, as there was general agreement within the Republican caucus that the spending bill could return to the Senate without further changes.

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

Since 2018, cannabis products have been considered legal hemp if they contain less than 0.3 percent delta-9 THC by dry weight.

The new legislation specifies that, within a year of taking effect, the weight will be applied to total THC—including delta-8 and other isomers. Also, “as tetrahydrocannabinol (or any other marketed cannabinoid) with similar effects in humans or animals (as determined by the Secretary of Health and Human Services).”

The new definition of legal hemp will also prohibit “any hemp-derived cannabinoid intermediate product marketed or sold as an end product or directly to an end consumer for personal or home use” as well as products containing cannabinoids that are synthesized or manufactured outside of the cannabis plant or are unable to produce it naturally.

Legal hemp products will be limited to a total of 0.4 milligrams of total THC or any other cannabinoid with similar effects per container.

Within 90 days of the bill’s passage, the Food and Drug Administration (FDA) and other agencies must “publish a list of all cannabinoids known to the FDA to be naturally produced by a Cannabis sativa L. plant, as reflected in the peer-reviewed literature,” which include “all tetrahydrocannabinol classes known” in natural plants and “known cannabinoids.” cannabinoids that have or are marketed as having effects similar to cannabinoids of the tetrahydrocannabinol class.

The language differs slightly from provisions in legislation advanced out of the House and Senate Appropriations panels, which would have banned products with “quantifiable” amounts of THC, to be determined by the HHS secretary and the agriculture secretary.

Meanwhile, advocates are strongly criticizing congressional leaders for advancing a spending bill ahead of Veterans Day on Tuesday, which also omits bipartisan provisions. Allowing the US Department of Veterans Affairs (VA) to prescribe medical cannabis to doctors to patients in states where it is legal—although the policy was approved by the full Senate and House earlier this year.

Read about the VFWs the letter To Congress on the hemp ban below:

Brendan Cleak’s photo.

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Related Topics:
Continue Reading

Cannabis News

New Plant Improvement Act comes into effect

Published

18 hours ago

on

December 27, 2025

By











The South African Department of Agriculture has announced that the Plant Improvement Act 2018 (Act 11 of 2018) and accompanying regulations came into force on 1 December 2025. President Cyril Ramaphosa signed the proclamation of the new Act after Agriculture Minister John Steenhuisen approved the regulations. The Act replaces the Plant Improvement Act 1976 (Act 53 of 1976). Both the proclamation and its regulations were published in Official Gazette 53707 of November 21, 2025.

The updated legislation establishes systems for the registration of businesses related to plants and propagating materials for cultivation and sale, as well as the registration of the premises where these businesses operate. It also establishes quality standards for plants and propagating material, determines sales conditions and establishes a national list of plant varieties. The law includes processes for evaluating plant varieties when there is uncertainty about their value for cultivation and use, and strengthens import and export control of plants and propagating material. Certification schemes for plants and propagating material are also part of the framework.

The 2018 Act introduces new provisions that were not included in the 1976 Act. These additions include the registration of businesses related to plants and propagating material, along with new rules for the cultivation of Cannabis sativa L. (hemp) varieties in South Africa. The revised definition now classifies hemp as a low tetrahydrocannabinol (THC) plant or plant part containing no more than 2 percent transdelta 9 THC, a change from the previous limit of 0.2 percent. The Act also provides for the publication of a Gazette of the National List of Varieties and specifies the process for hearing claims submitted to the Registry in connection with applications for the National List of Plant Varieties. In addition, the Law establishes an advisory committee that can assist the Registry in technical or administrative matters related to its implementation.

According to the department, the Plant Improvement Act creates a legal framework for the production and sale of high-quality seeds and vegetative propagation material. This framework supports the productivity and long-term sustainability of food production in South Africa.

Source: South African Government News Agency










Continue Reading

Cannabis News

Trump’s Marijuana Order Means Congress Must Delay The Federal Hemp Ban’s Timeline (Op-Ed)

Published

18 hours ago

on

December 27, 2025

By

“Congress, you have orders from the president. Extend the implementation period of the hemp ban.”

By Adam Terry, Cantrip

As it was widely reported, last week the entire cannabis universe watched as President Donald Trump signed an executive order to change marijuana from schedule I to III. What wasn’t as widely reported was what Trump also did: He addressed lawmakers again on the law As Congress passed the new definition of hemp last month.

The exact text of the executive order reads:

“The Assistant to the President and Deputy Chief of Staff for Legislative, Policy, and Public Affairs will work with Congress to update the final statutory definition of hemp-derived cannabinoid products to ensure that Americans have access to appropriate full-spectrum CBD products, in line with Congress’ intent to reduce the sale of products that pose serious health risks…”

This provision is careful and detailed. He directs a deputy chief of staff to work with Congress to update the new definition of hemp, directly acknowledging what the hemp industry has been saying for weeks: full-spectrum CBD products are not eligible under this new language.

He specifically acknowledges that if CBD products are to be subsidized or covered by Medicare, as is part of Trump’s plan, those products will be hemp-derived.

Full-spectrum CBD is a staple for many Americans. It is a lifesaver for veterans and senior citizens who rely on these products for various therapeutic purposes. It is a crucial element for some people with epilepsy, including pediatric patients. I’ve had moms and dads message me that Epidiolex, a federally approved CBD prescription drug, wasn’t working for their kids, and instead they were relying on other CBD products to find relief for their kids.

This is not just politics for them, but a stark reality.

You can’t have full-spectrum CBD with only 0.4 mg of THC per container, as required by the newly enacted change to the federal definition of hemp, and the president acknowledged that in his executive order, I’m sure with counsel to groups like the Commonwealth Project who were at the signing. Therefore, it is very likely that the definition of hemp will be reopened and legalized.

So here’s the bottom line: this conversation will take time, and probably longer than hemp has left before the ban comes into force late next year. While I have been working with the New Jersey legislature for nearly three years to craft a bill to regulate hemp cannabinoids in a way that does not diminish the CBD market, it has yet to make full impact in the state due to this complexity.

This means that the best first step for Congress to take is to extend the deadline for implementing a revised definition of hemp to ensure access to full-spectrum CBD for the tens of millions of Americans who will lose access next November if this language is enacted.

With 2026 being a close election year, most legislation will slow down after April, so it is unlikely that a final bill updating this language and regulating hemp cannabinoids will reach the finish line until the next Congress, which begins in January 2027. And the extension must pass soon, because farmers can’t plant in the spring if their harvest is in time.

I look forward to the next interview. Hemp needs to be regulated in this country, that much is clear. The White House has just sent a signal that prohibitionist redefinition cannot stand if the people who rely most on cannabis are to do well, especially in red states that voted for this president and those who have no access to cannabis outside of hemp products.

Congress, you have orders from the president. Extend the implementation period of the hemp ban, and let’s do the real hard work to craft legislation that includes safe access to cannabis for Americans in this great nation.

Adam Terry is the co-founder and CEO of THC-infused beverage company Cantrip.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Greenhouse hygiene programs emphasize deep-penetration sanitation during cleanouts

Published

2 days ago

on

December 26, 2025

By

During winter clean-ups, greenhouse operators prepare facilities for the next production cycle, with hygiene remaining a critical focus. Effective sanitation during crop transition plays a key role in reducing pathogen pressure and promoting long-term crop health, particularly in operations that manage virus risks such as Tomato brown rugose fruit virus (ToBRFV).

Disinfectants commonly included in greenhouse hygiene programs include Intra Multi Des GA, supplied in North America by Houweling Americas. “This product is widely used by vegetable and ornamental growers as part of comprehensive cleaning and routine sanitation strategies, especially where deep penetration is required on complex surfaces,” says the Houweling Americas team.

© Houweling Americas

Getting under the surface
Biofilms and organic debris continue to limit the effectiveness of many disinfectants, harboring microorganisms in cracks, crevices, and porous materials. According to the Multi Des GA technical team, the formulation is designed to address this challenge through penetration rather than surface activity.

“Intra Multi Des GA has five active ingredients that work together to provide strong penetration properties, allowing the product to reach microorganisms hiding in difficult access areas,” the team explained. While not positioned as a dedicated biofilm remover, the formulation is intended to reveal and eliminate pathogens sheltered beneath biofilm layers.

For best results, a two-step sanitation approach is recommended: deep cleaning to remove organic matter and biofilm, followed by disinfection. “Skip the cleaning step increases the risk of completely eliminating pathogens,” the team noted, highlighting the continued opportunity for farmer education around proper hygiene sequencing.

The role of cleaning before disinfection
As part of the Intracare product portfolio, Houweling Americas also supplies Intra Foam Organics, a cleaner designed to remove organic material prior to disinfection. Organic debris can significantly reduce disinfectant performance if not completely removed, especially on high-traffic or porous surfaces. When used as a first step, cleaners like Intra Foam Organics help ensure that disinfectants can come into direct contact with target pathogens.

Performance on porous and uneven surfaces
Concrete floors, block walls and other porous greenhouse materials remain among the most difficult areas to sanitize. According to internal tests, Intra Multi Des GA works reliably on these surfaces, moving into the micro-cracks where pathogens can persist.

“When applied to porous materials such as concrete blocks, the formulation moves significantly across the substrate,” the team explained. “This behavior is different from traditional disinfectants that remain on the surface and do not reach the embedded microorganisms.”

© Houweling Americas

Broad spectrum pathogen control
Growers of all types of crops rely on Intra Multi Des GA to manage a wide range of pathogens, including fungal, bacterial and viral threats. The reported efficacy against ToBRFV has made it an essential component of hygiene protocols in tomato production.

“Intra Multi Des GA has shown excellent efficacy against ToBRFV and has proven effective in eliminating the virus on contact when used appropriately,” the team reported. Beyond viral control, growers also use the product against pathogens such as Fusarium and Pythium in crop and ornamental systems.

Waste behavior and crop turnover
Unlike non-residue disinfectants, Intra Multi Des GA is designed to leave a residual effect on treated surfaces during cleaning, providing extensive protection between crops. This waste is not intended to come into contact with the collected products, but is used to maintain sanitation during downtime.

Operational efficiency is another matter. The product is applied at a low concentration of use, requires a short contact time and usually requires only one application, allowing rapid crop rotations without compromising hygiene standards.

Long-term sanitation results
Growers who consistently incorporate Intra Multi Des GA have reported cumulative improvements in crop rotation hygiene programs over multiple seasons. In one documented case, a Dutch tomato operation managing ToBRFV reported no subsequent infections after integrating the product into the cleaning protocol.

“Starting clean remains one of the most effective ways to reduce the risk of early cycle infection,” the team emphasizes.

Supporting North American producers
Houweling Americas supplies Intra Multi Des GA and other Intracare solutions through established distribution partners and provides technical support to assist with implementation. In addition to hygiene products, the company’s portfolio includes nutrient solutions, growing substrates, LED lighting, water treatment technologies and biostimulants such as Intra Eco Shield, with Intra Boost, a next-generation willow bark-derived biostimulant, scheduled for a North American launch in early 2026.

Based in British Columbia and Ontario, Houweling Americas works closely with growers to develop integrated solution programs that support yield, plant health and resilience. The company is part of Royal Houweling, a Dutch family business founded in 1925 and recently recognized with royal status for its long-term commitment to horticulture and sustainability.

For growers seeking technical guidance on hygiene protocols or product performance, the Houweling Americas team encourages direct engagement for further assistance.

For more information:
Houweling America
1-800-252-5824
houwelingamericas.com

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media